339 related articles for article (PubMed ID: 19303825)
21. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients.
Vitellas KM; El-Dieb A; Vaswani KK; Bennett WF; Fromkes J; Ellison C; Bova JG
AJR Am J Roentgenol; 2002 Aug; 179(2):409-16. PubMed ID: 12130442
[TBL] [Abstract][Full Text] [Related]
22. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks].
Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C
J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779
[TBL] [Abstract][Full Text] [Related]
23. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging--ROC analysis.
Nishiharu T; Yamashita Y; Abe Y; Mitsuzaki K; Tsuchigame T; Nakayama Y; Takahashi M
Radiology; 1999 Aug; 212(2):445-52. PubMed ID: 10429702
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
[TBL] [Abstract][Full Text] [Related]
25. MR-cholangiopancreaticography (MRCP) and MR-angiography: morphologic changes with magnetic resonance imaging.
Vahldiek G; Broemel T; Klapdor R
Anticancer Res; 1999; 19(4A):2451-8. PubMed ID: 10470174
[TBL] [Abstract][Full Text] [Related]
26. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
[TBL] [Abstract][Full Text] [Related]
27. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
28. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
[TBL] [Abstract][Full Text] [Related]
29. Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography.
Bridges MD; May GR; Harnois DM
AJR Am J Roentgenol; 2004 Jun; 182(6):1497-504. PubMed ID: 15149996
[TBL] [Abstract][Full Text] [Related]
30. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT.
Schima W; Függer R
Eur Radiol; 2002 Dec; 12(12):2998-3008. PubMed ID: 12439582
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis.
Sheridan MB; Ward J; Guthrie JA; Spencer JA; Craven CM; Wilson D; Guillou PJ; Robinson PJ
AJR Am J Roentgenol; 1999 Sep; 173(3):583-90. PubMed ID: 10470884
[TBL] [Abstract][Full Text] [Related]
33. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW
J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
[TBL] [Abstract][Full Text] [Related]
34. Secretin-assisted CT of the pancreas: improved pancreatic enhancement and tumour conspicuity.
O'Connell AM; Lyon SM; O'Sullivan P; Given MF; Morrin M; Lee MJ
Clin Radiol; 2008 Apr; 63(4):401-6. PubMed ID: 18325360
[TBL] [Abstract][Full Text] [Related]
35. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
Gehl HB; Urhahn R; Bohndorf K; Klever P; Hauptmann S; Lodemann KP; Matern S; Schumpelick V; Günther RW
Radiology; 1993 Mar; 186(3):795-8. PubMed ID: 8430190
[TBL] [Abstract][Full Text] [Related]
36. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
Yeh BM; Breiman RS; Taouli B; Qayyum A; Roberts JP; Coakley FV
Radiology; 2004 Mar; 230(3):645-51. PubMed ID: 14990830
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T.
Vellet AD; Romano W; Bach DB; Passi RB; Taves DH; Munk PL
Radiology; 1992 Apr; 183(1):87-95. PubMed ID: 1312736
[TBL] [Abstract][Full Text] [Related]
38. Bile duct leaks after laparoscopic cholecystectomy: value of contrast-enhanced MRCP.
Aduna M; Larena JA; Martín D; Martínez-Guereñu B; Aguirre I; Astigarraga E
Abdom Imaging; 2005; 30(4):480-7. PubMed ID: 15688109
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension.
Mehmet Erturk S; Ichikawa T; Sou H; Saitou R; Tsukamoto T; Motosugi U; Araki T
J Comput Assist Tomogr; 2006; 30(4):583-90. PubMed ID: 16845288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
